Jonathan A. Ledermann
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments, BRCA gene mutations in cancer, Intraperitoneal and Appendiceal Malignancies
Most-Cited Works
- → Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer(2016)2,417 cited
- → A Phase 3 Trial of Bevacizumab in Ovarian Cancer(2011)2,134 cited
- → Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer(2012)1,873 cited
- → ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma(2020)1,861 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Ovarian cancer(2014)1,842 cited
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial(2014)1,433 cited
- → ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up(2015)1,359 cited
- → Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial(2003)1,195 cited